LENG9 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.760600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.522200E-01
Normal-vs-Stage2
8.471800E-01
Normal-vs-Stage3
9.341800E-01
Normal-vs-Stage4
4.985600E-01
Stage1-vs-Stage2
8.762800E-01
Stage1-vs-Stage3
6.004000E-01
Stage1-vs-Stage4
5.605600E-01
Stage2-vs-Stage3
7.572200E-01
Stage2-vs-Stage4
2.327000E-01
Stage3-vs-Stage4
4.237000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.529400E-01
Normal-vs-AfricanAmerican
8.275200E-01
Normal-vs-Asian
3.564600E-01
Caucasian-vs-AfricanAmerican
7.898200E-01
Caucasian-vs-Asian
9.599900E-02
AfricanAmerican-vs-Asian
2.655400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.602800E-01
Normal-vs-Female
8.692000E-01
Male-vs-Female
5.466200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.410800E-01
Normal-vs-Age(41-60Yrs)
6.796800E-01
Normal-vs-Age(61-80Yrs)
7.786000E-01
Normal-vs-Age(81-100Yrs)
5.147200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.939400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.683200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.614000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.589590E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.567800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.201200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.782600E-01
Normal-vs-Daily Drinker
4.588200E-01
Normal-vs-Weekly Drinker
4.625800E-01
Normal-vs-Occasional Drinker
8.190400E-01
Normal-vs-Social Drinker
9.469400E-01
Non Drinker-vs-Daily Drinker
7.684400E-02
Non Drinker-vs-Weekly Drinker
1.476840E-01
Non Drinker-vs-Occasional Drinker
6.080800E-01
Non Drinker-vs-Social Drinker
9.377800E-01
Daily Drinker-vs-Weekly Drinker
9.169400E-01
Daily Drinker-vs-Occasional Drinker
2.710000E-01
Daily Drinker-vs-Social Drinker
1.142400E-01
Weekly Drinker-vs-Occasional Drinker
3.474000E-01
Weekly Drinker-vs-Social Drinker
1.795030E-01
Occasional Drinker-vs-Social Drinker
7.217600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.704000E-01
Normal-vs-Grade 2
9.643000E-01
Normal-vs-Grade 3
9.151600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.891820E-01
Grade 1-vs-Grade 3
2.035800E-01
Grade 1-vs-Grade 4
7.704000E-01
Grade 2-vs-Grade 3
8.543400E-01
Grade 2-vs-Grade 4
9.643000E-01
Grade 3-vs-Grade 4
9.151600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.847600E-01
Normal-vs-NonDiabetic
8.391800E-01
Diabetic-vs-NonDiabetic
6.175200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.790200E-01
Normal-vs-NoPancreatitis
8.703200E-01
Pancreatitis-vs-NoPancreatitis
2.085400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.860400E-01
Normal-vs-N1
9.836200E-01
N0-vs-N1
1.425770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.804400E-01
Normal-vs-TP53-NonMutant
9.426000E-01
TP53-Mutant-vs-TP53-NonMutant
9.830200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
